GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » 3-Year FCF Growth Rate

Hainan Poly Pharm Co (SZSE:300630) 3-Year FCF Growth Rate : -34.60% (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co 3-Year FCF Growth Rate?

Hainan Poly Pharm Co's Free Cash Flow per Share for the three months ended in Sep. 2023 was ¥-0.15.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -34.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -46.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 11 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Hainan Poly Pharm Co was -11.90% per year. The lowest was -78.00% per year. And the median was -57.40% per year.


Competitive Comparison of Hainan Poly Pharm Co's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Poly Pharm Co's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Poly Pharm Co's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Poly Pharm Co's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Hainan Poly Pharm Co's 3-Year FCF Growth Rate falls into.



Hainan Poly Pharm Co 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Hainan Poly Pharm Co  (SZSE:300630) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Hainan Poly Pharm Co 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Poly Pharm Co (SZSE:300630) Business Description

Traded in Other Exchanges
N/A
Address
No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051
Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines